Bill > HR6575

This bill, the Medicare Prescription Drug Savings and Choice Act of 2018, aims to establish a Medicare-operated prescription drug plan option in addition to the existing private plans. The key provisions of the bill are: 1. The Secretary of Health and Human Services would be required to offer one or more Medicare-operated prescription drug plans with nationwide coverage and negotiate drug prices with pharmaceutical manufacturers to reduce costs for Medicare beneficiaries enrolled in these plans. 2. The Secretary would be required to establish a formulary for the Medicare-operated plan, based on recommendations from the Agency for Healthcare Research and Quality, to increase patient safety, appropriate use of drugs, and value. The formulary could include tiered copayments, reference pricing, and other incentives to encourage use of drugs with greater clinical benefit and lower cost. 3. The bill would also require the Secretary to develop an efficient and well-defined appeals process for the Medicare-operated plan to allow beneficiaries to obtain non-formulary drugs or exemptions from formulary incentives when medically necessary.

Business and Industry, Health and Social Services

https://www.congress.gov/bill/115th-congress/house-bill/6575/all-info